Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (VERA)

CUSIP: 92337R101

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Class A common stock, $0.001 par value per share
Shares outstanding
71,297,491
Total 13F shares
41,345,437
Share change
+2,843,017
Total reported value
$635,880,813
Put/Call ratio
487%
Price per share
$15.38
Number of holders
93
Value change
+$44,778,975
Number of buys
51
Number of sells
31

Quarterly Holders Quick Answers

What is CUSIP 92337R101?
CUSIP 92337R101 identifies VERA - Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (VERA) as of Q4 2023

As of 31 Dec 2023, Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (VERA) was held by 93 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 41,345,437 shares. The largest 10 holders included COMMODORE CAPITAL LP, Kynam Capital Management, LP, Sofinnova Investments, Inc., FMR LLC, BlackRock Inc., Woodline Partners LP, STATE STREET CORP, Eversept Partners, LP, VANGUARD GROUP INC, and ORBIMED ADVISORS LLC. This page lists 93 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.